H.R. 7871: MVP Act

H.R. 7871 is a federal bill in the 119th Congress. Before this legislation, federal rules made it difficult for drug manufacturers to offer variable pricing in Medicaid based on how well a treatment worked without accidentally lowering their baseline price across the board. After this bill takes effect,… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.